Federal Supply Schedule 36F79722D0084
Award Date
3/15/22
Last Date to Order
3/14/27
Federal Agency
Veterans Integrated Service Network 12
Awardee
Shield Therapeutics Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to H2-Pharma LLC, a for-profit limited liability company, to provide pharmaceuticals and hematology-related products. The contract has a ceiling value of $225,000.00 and a period of performance from October 1, 2018 to October 1, 2025. The FSS contract, part of the Pharmaceuticals and Drugs (FSS-61-IB) schedule, is a multiple award vehicle that allows federal agencies to procure the...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
The Federal Supply Schedule (FSS) contract awarded to Fera Pharmaceuticals, LLC is for the procurement of pharmaceutical drugs, pharmaceuticals, and hematology-related products. The prime contractor, Fera Pharmaceuticals, is a woman-owned small business that supplies the Department of Veterans Affairs (VA) and other government agencies with these products. The FSS contract, valued at up to $450,000.00, was awarded by the VA's Veterans Health Administration Veterans Integrated Service Network...
The Federal Supply Schedule (FSS) contract 36F79718D0461 was awarded to Prime Contractor Para Pro LLC, a small disadvantaged business and veteran-owned manufacturer of goods, to provide pharmaceuticals and related hematology products. The contract has a $250,000 ceiling value and a performance period ending on May 31, 2025. This multiple award FSS contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and was awarded by the Department of Veterans Affairs, Veterans...
The Federal Supply Schedule (FSS) Contract No. V797D70214 was awarded by the Department of Veterans Affairs (VA) to STI Pharma LLC, a for-profit limited liability company manufacturer of goods. The contract is under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule, with a ceiling value of $225,000.00 and a period of performance through May 14, 2026. The contract aims to procure a range of pharmaceutical and hematology-related products for the VA, which is a civilian agency. No...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
The Federal Supply Schedule (FSS) contract 36F79720D0115 was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Secura Bio, Inc., a for-profit manufacturer, on April 1, 2020. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) Master Schedule and has a ceiling value of $250,000.00. It is a multiple award contract with no set-asides, and the period of performance runs through September 30, 2025. The purpose of the contract is to provide drugs,...
This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to G1 Therapeutics, Inc. for the provision of pharmaceutical and drug products. The contract has a ceiling value of $2,250,000.00 and a period of performance through July 14, 2026. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and allows for the delivery of a broad range of drug and hematology-related products to the VA and its related healthcare...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Federal Supply Schedule (FSS) contract to Vistapharm, Inc., a for-profit manufacturer of pharmaceutical goods. The contract, with a potential value of $20,359,397, is under the VA's Veterans Integrated Service Network 12 and is part of the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract has a period of performance from September 30, 2017, to March 31, 2024, and does not utilize any...
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Acerus Pharmaceuticals Corporation. The contract, valued up to $750,000.00, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from May 15, 2021, to May 14, 2026. As an FSS contract, this is a multiple-award vehicle that provides federal agencies with a streamlined purchasing process to...